Rx (Prescription Medicine)
USD $ 145.00
Cazanat 60mg Tablet 是一种主要用于其抗糖尿病特性的药物。其活性成分是达帕格列净，属于钠-葡萄糖共转运蛋白-2（SGLT2）抑制剂。达帕格列净通过阻断肾脏中葡萄糖的重吸收，增加尿中的葡萄糖排泄量。该机制有助于降低血糖水平，用于治疗2型糖尿病患者。通过降低血糖，Cazanat 60mg Tablet 可帮助改善糖尿病患者的血糖控制，并降低糖尿病相关并发症的风险。通常作为饮食和运动的辅助治疗，用于管理2型糖尿病。常规剂量为每日一次口服一片。常见的不良反应可能包括尿路感染、外阴酵母菌感染和尿频。有严重肾功能不全或既往某些疾病史的患者在使用前应咨询医生。请将Cazanat 60mg Tablet 存放于室温，避免潮湿和直射光。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Cabozantinib 60 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
